By Associate Professor Madlen Gazarian

Book Chapters

Sri Ranganathan S; Gazarian M, 2015, 'Rational use of medicines (RUM) for children in the developing world: Current status, key challenges and potential solutions', in Optimizing Treatment for Children in the Developing World, pp. 225 - 238, http://dx.doi.org/10.1007/978-3-319-15750-4_20

Gazarian M; Laxer R, 2001, 'Pharmacology and Drug Therapy', in Textbook of Pediatric Rheumatology, W B Saunders Company, USA

Journal articles

Mumford V; Raban MZ; Li L; Fitzpatrick E; Woods A; Merchant A; Badgery-Parker T; Gates P; Baysari M; Day RO; Ambler G; Dalla-Pozza L; Gazarian M; Gardo A; Barclay P; White L; Westbrook JI, 2024, 'Developing a process to measure actual harm from medication errors in paediatric inpatients: From design to implementation', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.16052

Gazarian M; Horton DB; Carleton B; Kinlaw AC; Bushnell GA; Czaja AS; Durrieu G; Gorman EF; Titievsky L; Zito J; Slaughter JL; dosReis S, 2023, 'Optimizing therapeutic decision-making for off-label medicines use: A scoping review and consensus recommendations for improving practice and research⁺', Pharmacoepidemiology and Drug Safety, 32, pp. 1200 - 1222, http://dx.doi.org/10.1002/pds.5640

Westbrook JI; Li L; Raban MZ; Mumford V; Badgery-Parker T; Gates P; Fitzpatrick E; Merchant A; Woods A; Baysari M; McCullagh C; Day R; Gazarian M; Dickinson M; Seaman K; Dalla-Pozza L; Ambler G; Barclay P; Gardo A; O’Brien T; Barbaric D; White L; O'Brien T, 2022, 'Short- and long-term effects of an electronic medication management system on paediatric prescribing errors', npj Digital Medicine, 5, pp. 179, http://dx.doi.org/10.1038/s41746-022-00739-x

Westbrook JI; Li L; Raban MZ; Woods A; Koyama AK; Baysari MT; Day RO; McCullagh C; Prgomet M; Mumford V; Dalla-Pozza L; Gazarian M; Gates PJ; Lichtner V; Barclay P; Gardo A; Wiggins M; White L, 2021, 'Associations between double-checking and medication administration errors: A direct observational study of paediatric inpatients', BMJ Quality and Safety, 30, pp. 320 - 330, http://dx.doi.org/10.1136/bmjqs-2020-011473

Ghinea N; Critchley C; Morrell B; Kerridge I; Campbell T; Day R; Gazarian M; Isaacs D; Liauw W; Olver I; Pace J; Pearson S; Salkeld G; Lipworth W, 2021, 'A survey of Australian public attitudes towards funding of high cost cancer medicines', Health Policy, 125, pp. 327 - 334, http://dx.doi.org/10.1016/j.healthpol.2020.12.002

Gates PJ; Baysari MT; Gazarian M; Raban MZ; Meyerson S; Westbrook JI, 2019, 'Prevalence of Medication Errors Among Paediatric Inpatients: Systematic Review and Meta-Analysis', Drug Safety, 42, pp. 1329 - 1342, http://dx.doi.org/10.1007/s40264-019-00850-1

Westbrook JI; Li L; Raban MZ; Baysari MT; Mumford V; Prgomet M; Georgiou A; Kim T; Lake R; McCullagh C; Dalla-Pozza L; Karnon J; O'Brien TA; Ambler G; Day R; Cowell CT; Gazarian M; Worthington R; Lehmann CU; White L; Barbaric D; Gardo A; Kelly M; Kennedy P, 2016, 'Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: A study protocol', BMJ Open, 6, pp. e011811, http://dx.doi.org/10.1136/bmjopen-2016-011811

De Bie S; Ferrajolo C; Straus SMJM; Verhamme KMC; Bonhoeffer J; Wong ICK; Sturkenboom MCJM; Giaquinto C; Gazarian M; Ceci A; Weereasuriya K; Hirschfeld S; Saint Raymond A; Nakamura H; Sharland M; Offringa M; Hoppu K, 2015, 'Pediatric drug safety surveillance in FDA-AERS: A description of adverse events from GRiP project', PLoS ONE, 10, http://dx.doi.org/10.1371/journal.pone.0130399

Denaro C; Gazarian M; Morris S, 2015, 'Council of Australian therapeutic advisory groups: Supporting the quality use of medicines across the acute-care sector', Internal Medicine Journal, 45, pp. 369 - 371, http://dx.doi.org/10.1111/imj.12709

Osokogu OU; Fregonese F; Ferrajolo C; Verhamme K; de Bie S; Jong G; Catapano M; Weibel D; Kaguelidou F; Bramer WM; Hsia Y; Wong ICK; Gazarian M; Bonhoeffer J; Sturkenboom M, 2015, 'Pediatric Drug Safety Signal Detection: A New Drug–Event Reference Set for Performance Testing of Data-Mining Methods and Systems', Drug Safety, 38, pp. 207 - 217, http://dx.doi.org/10.1007/s40264-015-0265-0

Lumsden G; McLaren P; Gazarian M; Drew A; Bennett A, 2014, 'Intravenous paracetamol in paediatrics: cause for concern', Australian Prescriber, 37, pp. 152 - 153, http://dx.doi.org/10.18773/austprescr.2014.064

Gazarian M; Morris S, 2014, 'Off -label prescribing', Medical Journal of Australia, 200, pp. 637, http://dx.doi.org/10.5694/mja14.00577

Gazarian M; Drew A; Bennett A, 2014, 'Medicinal mishap intravenous paracetamol in paediatrics: Cause for caution', Australian Prescriber, 37, pp. 24 - 25, http://dx.doi.org/10.18773/austprescr.2014.007

Osokogu O; Fregonese F; Weibel D; Verhamme K; Catapano M; De Bie S; Sturkenboom M; Ferrajolo C; Coloma P; t'Jong G; Schuemie M; Wong I; Hsia Y; Gazarian M; Nakamura H, 2013, 'Creating a Reference Set for Comparing Data Mining Methods and Evaluating Database Performance in Children - The GRiP Project', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 344 - 344, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yamashiro Y; Martin J; Gazarian M; Kling S; Nakamura H; Matsui A; Cucchiara S; Aloi M; Wynn EL; Mulberg AE, 2012, 'Drug development: The use of unlicensed/off-label medicines in pediatrics', Journal of Pediatric Gastroenterology and Nutrition, 55, pp. 506 - 510, http://dx.doi.org/10.1097/MPG.0b013e318272af1f

Gazarian M; Graudins LV, 2012, 'Long-term reduction in adverse drug events: An evidence-based improvement model', Pediatrics, 129, pp. 1 - 9, http://dx.doi.org/10.1542/peds.2011-1902

Carney SL; Gazarian M; Denholm JT; Reith DM; Penhall RK; Jenkins CR; Wilhelm KA; Komesaroff PA; Osborn MM; Day RO, 2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651, http://dx.doi.org/10.5694/mja10.10968

Best EJ; Gazarian M; Cohn RJ; Wilkinson M; Palasanthiran P, 2011, 'Once-daily gentamicin in infants and children: A prospective cohort study evaluating safety and the role of therapeutic drug monitoring in minimizing toxicity', Pediatric Infectious Disease Journal, 30, pp. 827 - 832, http://dx.doi.org/10.1097/INF.0b013e31821e405d

Lowinger JS; Stark HE; Kelly M; Hughes CF; Gazarian M; Kaye KI, 2010, 'Improving use of medicines with clinician-led use of validated clinical indicators', Medical Journal of Australia, 192, pp. 180 - 189, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03473.x

Mallarkey G; Brighton T; Thomson A; Kaye KI; Seale P; Gazarian M, 2008, 'An evaluation of eptacog alfa in nonhaemophiliac conditions', Drugs, 68, pp. 1665 - 1689

Hilmer S; Gazarian M, 2008, 'Clinical pharmacology in special populations: the extremes of age', Expert Reviews in Clinical Pharmacology, 1, pp. 467 - 469

Osmond MH; Gazarian M; Henry RL; Clifford TJ; Tetzlaff J, 2007, 'Barriers to Metered-dose Inhaler/spacer Use in Canadian Pediatric Emergency Departments: A National Survey', Academic Emergency Medicine, 14, pp. 1106 - 1113, http://dx.doi.org/10.1197/j.aem.2007.05.009

Osmond M; Gazarian M; Henry RL; Clifford T; Tetzlaff J, 2007, 'Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: A national survey', Academic Emergency Medicine, 14, pp. 1106 - 1113

Gazarian M; Graudins LV, 2006, 'Safe use of NSAIDs in infants and children', Medicine Today, 7, pp. 71 - 73

Graudins LV; Gazarian M, 2006, 'Promoting safe use of paracetamol in children', Journal of Pharmacy Practice and Research, 36, pp. 297 - 300, http://dx.doi.org/10.1002/j.2055-2335.2006.tb00633.x

Gazarian M; Kelly M; McPhee J; Graudins LV; Ward RL; Campbell TJ, 2006, 'Off label use of medicines: consensus recommendations for evaluating appropriateness', Medical Journal of Australia, 185, pp. 544 - 548

Gazarian M, 2006, 'The current situation of medicinal products in children: Therapeutic orphans for 50 years', ACTA Pharmacologica Sinica, 27, pp. 4 - 4

Kelly M; Gazarian M; McPhee J, 2005, 'Letters to the Editor: Off-label prescribing', Australian Prescriber, 28, pp. 5 - 7, http://dx.doi.org/10.18773/austprescr.2005.005

Best EJ; Palasanthiran P; Gazarian M, 2005, 'Extended-interval aminoglycosides in children: More guidance is needed', Pediatrics, 115, pp. 827 - 828

Gazarian M; McPhee J; Kelly MM, 2005, 'Off label prescribing', Australian Prescriber, 28, pp. 7 - 7

Kelly M; Campbell TJ; Gazarian M; Graudins LV; McPhee J; Kaye KI, 2004, 'Guidelines for off-label use of medicines', Clinical and Experimental Pharmacology and Physiology, 31, pp. A226 - A226

Uziel Y; Berkovitch M; Gazarian M; Koren G; Silverman ED; Schneider R; Laxer R, 2003, 'Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in childern with juvenile rheumatoid arthritis: A double blind, randomized, placebo controlled trial', Journal of Rheumatology, 30, pp. 594 - 596

Gazarian M, 2003, 'Why are children still therapeutic orphans?', Australian Prescriber, 26, pp. 122 - 123

Vitry AI; Hurley E; Gazarian M; Kaye KI; Edmonds JP; Day RO; Bertouch JV, 2002, 'The road to consensus: Considerations for the safe use and prescribing of COX-2-specific inhibitors (multiple letters)', Medical Journal of Australia, 177, pp. 572 - 573, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04959.x

Gazarian M; Murray K; Roberton D, 2002, 'Letters to the Editor: Discontinuation of naproxen suspension', Australian Prescriber, 25, pp. 104 - 107, http://dx.doi.org/10.18773/austprescr.2002.108

Graudins LV; Gazarian M, 2002, 'Celecoxib Use and Overuse-Too Much `Celebration`', Journal of Pharmacy and Research, 32, pp. 104 - 107

Cotterell EM; Gazarian M; Henry RL; O Meara M; Wales S, 2002, 'Child and Parent Satisfaction with the Use of Spacer Devices in Acute Asthma', Journal of Paediatrics and Child Health (Vol. 48, Suppl. 2, 2012, 1–13), 38, pp. 604 - 607

Gazarian M; Murray K; Roberton D, 2002, 'Discontinuation of Naproxen Suspension', Australian Prescriber, 25, pp. 106 - 107

Gazarian M; Kaye KI, 2002, 'The road to consensus: considerations for teh safe use and prescribing of COX-2- specific inhibitors', Medical Journal of Australia, 177, pp. 572 - 573

Gazarian M, 2001, 'EBM in practice: paediatrics', EBM, 174, pp. 586 - 587

Gazarian M; Henry RL; Wales S; Micallef B; Rood EM; O Meara M; Numa AH, 2001, 'Evaluating the effectiveness of evidence-based guidelines for the use of spacer devices in children with acute asthma', Medical Journal of Australia, 174, pp. 394 - 397

Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks PM; Day RO; Strand V; Wells G, 1999, 'Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress for the OMERACT drug toxicity working party', Journal of Rheumatology, pp. 207 - 209

Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks PM; Day RO; Strand V; Wells G, 1999, 'Patient based methods for assessing adverse events in clinical trials in Rheumatology. Progress report for the Omeract Drug Toxicity Working Party', Journal of Rheumatology, pp. 207 - 209

Gazarian M; Feldman B; Benson L; Gilday D; Laxer R; Silverman ES, 1998, 'Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus', Journal of Pediatrics, 132, pp. 109 - 116

Gazarian M; Williams KM; Elliot E; Chant KG; Longbottom H; Mellis C; Nolan T; Oates R; Ruben A, 1998, 'Evaluation of a national surveillance unit', Archives of Disease in Childhood, pp. 21 - 27

Kim J; Gazarian M; Verjee Z; Johnson D, 1995, 'Acute renal insuffiency in ibuprofen overdose', Pediatric Emergency Care, 11, pp. 107 - 108, http://dx.doi.org/10.1097/00006565-199504000-00013

Gazarian M; Berkovitch M; Koren G; Silverman ED; Laxer RM, 1995, 'Experience with misoprostol therapy for NSAID gastropathy in children', Annals of the Rheumatic Diseases, 54, pp. 277 - 280, http://dx.doi.org/10.1136/ard.54.4.277

Gazarian M; Laxer RM; Kooh SW; Silverman ED, 1995, 'Hypoparathyroidism associated with systemic lupus erythematosus', Journal of Rheumatology, 22, pp. 2156 - 2158

Back to profile page